BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laser capture microdissection
,
Ciprofibrate
,
rs6983267
,
SLC12A1
,
Allergy to pollen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
FMR1NB
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Pneumonia
Disease due to West Nile virus
Testicular cancer
Interstitial lung disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
decitabine
5-azacytosine
A-83-01
E 616452
chiron
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Slx
Alkbh1
Slxl1
MAP3K4
ARID3A
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
FMR1NB Involved in Glioma Tumorigenesis Is a Promising Target for Prognosis and Therapy.
Targeted Isolation of Indole Alkaloids from Streptomyces sp. CT37.
Effect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cel…
Cancer/testis antigen NY-SAR-35 enhances cell proliferation, migration, and invasion.
A cancer/testis antigen, NY-SAR-35, induces EpCAM, CD44, and CD133, and activates ERK in HEK293 cell…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for FMR1NB
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ